Toggle navigation
Search All ICD-10
Toggle Dropdown
Search All ICD-10
ICD-10-CM Diagnosis Codes
ICD-10-PCS Procedure Codes
ICD-10-CM Diagnosis Index
ICD-10-CM External Causes Index
ICD-10-CM Table of Drugs
ICD-10-CM Table of Neoplasms
HCPCS Codes
ICD-9-CM Diagnosis Codes
ICD-9-CM Procedure Codes
Search All Data
2023
Codes
ICD-10-CM Codes
ICD-10-PCS Codes
Legacy ICD-9-CM Codes
Indexes
ICD-10-CM Index
ICD-10-CM External Causes Index
Table of Drugs
Table of Neoplasms
Conversion
DRG
Rules
ICD-10-CM
Newborn Codes
Pediatric Codes
Adult Codes
Maternity Codes
Female Only Diagnosis Codes
Male Only Diagnosis Codes
Manifestation Codes
POA Exempt Codes
Questionable Admission Codes
Billable/Specific Codes
Non-Billable/Non-Specific Codes
ICD-10-PCS
Female Only Procedure Codes
Male Only Procedure Codes
Analytics
Applicable To Crosswalk
Code Also Crosswalk
Code First Crosswalk
Includes Crosswalk
Note Crosswalk
Type 1 Excludes Crosswalk
Type 2 Excludes Crosswalk
Use Additional Crosswalk
Changes
ICD-10-CM
New 2023 Codes
Codes Revised in 2023
Codes Deleted in 2023
ICD-10-PCS
New 2023 Codes
Codes Revised in 2023
Codes Deleted in 2023
HCPCS
Codes
Modifiers
License Data Files
Disclaimer
ICD-10-PCS
›
3
›
E
›
0
›
Biliary and Pancreatic Tract
Biliary and Pancreatic Tract
3E0J
Biliary and Pancreatic Tract
3E0J3
Percutaneous
3E0J30
Antineoplastic
3E0J304
Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J305
Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J30M
Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J32
Anti-infective
3E0J328
Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J329
Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J33
Anti-inflammatory
3E0J33Z
Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J36
Nutritional Substance
3E0J36Z
Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J37
Electrolytic and Water Balance Substance
3E0J37Z
Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J3B
Anesthetic Agent
3E0J3BZ
Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J3G
Other Therapeutic Substance
3E0J3GC
Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J3H
Radioactive Substance
3E0J3HZ
Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J3K
Other Diagnostic Substance
3E0J3KZ
Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J3N
Analgesics, Hypnotics, Sedatives
3E0J3NZ
Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J3S
Gas
3E0J3SF
Introduction of Other Gas into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J3T
Destructive Agent
3E0J3TZ
Introduction of Destructive Agent into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J3U
Pancreatic Islet Cells
3E0J3U0
Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J3U1
Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Percutaneous Approach
3E0J4
Percutaneous Endoscopic
3E0J4G
Other Therapeutic Substance
3E0J4GC
Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Percutaneous Endoscopic Approach
3E0J7
Via Natural or Artificial Opening
3E0J70
Antineoplastic
3E0J704
Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J705
Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J70M
Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J72
Anti-infective
3E0J728
Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J729
Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J73
Anti-inflammatory
3E0J73Z
Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J76
Nutritional Substance
3E0J76Z
Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J77
Electrolytic and Water Balance Substance
3E0J77Z
Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J7B
Anesthetic Agent
3E0J7BZ
Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J7G
Other Therapeutic Substance
3E0J7GC
Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J7H
Radioactive Substance
3E0J7HZ
Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J7K
Other Diagnostic Substance
3E0J7KZ
Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J7N
Analgesics, Hypnotics, Sedatives
3E0J7NZ
Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J7S
Gas
3E0J7SF
Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J7T
Destructive Agent
3E0J7TZ
Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J7U
Pancreatic Islet Cells
3E0J7U0
Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J7U1
Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening
3E0J8
Via Natural or Artificial Opening Endoscopic
3E0J80
Antineoplastic
3E0J804
Introduction of Liquid Brachytherapy Radioisotope into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J805
Introduction of Other Antineoplastic into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J80M
Introduction of Antineoplastic, Monoclonal Antibody, into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J82
Anti-infective
3E0J828
Introduction of Oxazolidinones into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J829
Introduction of Other Anti-infective into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J83
Anti-inflammatory
3E0J83Z
Introduction of Anti-inflammatory into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J86
Nutritional Substance
3E0J86Z
Introduction of Nutritional Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J87
Electrolytic and Water Balance Substance
3E0J87Z
Introduction of Electrolytic and Water Balance Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J8B
Anesthetic Agent
3E0J8BZ
Introduction of Anesthetic Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J8G
Other Therapeutic Substance
3E0J8GC
Introduction of Other Therapeutic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J8H
Radioactive Substance
3E0J8HZ
Introduction of Radioactive Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J8K
Other Diagnostic Substance
3E0J8KZ
Introduction of Other Diagnostic Substance into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J8N
Analgesics, Hypnotics, Sedatives
3E0J8NZ
Introduction of Analgesics, Hypnotics, Sedatives into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J8S
Gas
3E0J8SF
Introduction of Other Gas into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J8T
Destructive Agent
3E0J8TZ
Introduction of Destructive Agent into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J8U
Pancreatic Islet Cells
3E0J8U0
Introduction of Autologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic
3E0J8U1
Introduction of Nonautologous Pancreatic Islet Cells into Biliary and Pancreatic Tract, Via Natural or Artificial Opening Endoscopic